AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest

PURPOSE: The frequency in resistance to sorafenib accounts for the grim prognosis of advanced hepatocellular carcinoma (HCC). In the present study, we explore the anti-cancer efficacy of co-administration of sub-toxic AG-1024 with sorafenib in HCC cells to enhance the sensitivity of these cells to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Lou, Weiyang, Chen, Junru, Ding, Bisha, Chen, Binjie, Xie, Haiyang, Zhou, Lin, Zheng, Shusen, Jiang, Donghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894871/
https://www.ncbi.nlm.nih.gov/pubmed/33623392
http://dx.doi.org/10.2147/OTT.S289324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894871/
https://www.ncbi.nlm.nih.gov/pubmed/33623392
http://dx.doi.org/10.2147/OTT.S289324

Ejemplares similares